Helen C. Adams
Director · Immix Biopharma, Inc.
Individual
- 2026
- May 29, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Helen C. Adams files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gabriel S. Morris - $5K in IMMX purchases and sales in the last 12 months
- Ilya M. Rachman - $5K in IMMX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Helen C. Adams?
Helen C. Adams is a corporate insider, tracked as Director of Immix Biopharma, Inc. (IMMX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Helen C. Adams last file a Form 4?
The only primary Form 4 on record is dated 29 May 2026.
